指南与共识骨肌技术与安全

软组织肉瘤影像学推荐:从诊断到治疗后随访的模型指南

Imaging recommendations for soft-tissue sarcomas: model guidelines from diagnosis to post-treatment follow-up.
指南 / 共识 · Clin Radiol · 2024-09-07

本文探讨国际学会已发布的软组织肉瘤影像诊断、分期和随访指南,并描述影像学在评估复发和术后类似病变中的作用,旨在为放射科医生和临床医生提供软组织肉瘤管理各阶段有用的影像学指导。

要点

  • 软组织肉瘤是间叶来源的异质性恶性肿瘤,欧洲发病率为4-8/10万。
  • 2020年WHO分类将软组织肉瘤分为11大类,包含约80种实体。
  • 影像学可用于评估复发和术后类似病变,需结合指南在管理各阶段应用。

核心结论

  • 本文通过探讨国际学会已建立的软组织肉瘤影像诊断、分期和随访指南,为放射科医生和临床医生提供软组织肉瘤管理各阶段有用的影像学指导。

研究设计与样本

  • 本文为模型指南,探讨国际学会已建立的软组织肉瘤影像诊断、分期和随访指南,并描述影像学在评估复发和术后类似病变中的作用。

临床应用与阅片要点

  • 放射科医生和临床医生可将本文提供的影像学指导用于软组织肉瘤管理的各个阶段。
  • 影像学可用于评估软组织肉瘤复发和术后类似病变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Soft-tissue sarcomas (STSs) are a heterogeneous group of malignancies of mesenchymal origin with an incidence of 4-8 per 100,000 within Europe; they consist of various subtypes, each expressing distinct morphological, histopathological, and molecular features. According to the 2020 World Health Organization (WHO) classification, STSs are divided into 11 broad categories comprising approximately 80 entities. STS management guidelines are constantly evolving due to the development of newer diagnostic methods and treatments including the discovery of new chemotherapeutic agents and immunomodulators. Although the referral, diagnostic, and management pathways may vary in different healthcare systems, the core management principles remain the same. This article explores various established STS guidelines on imaging diagnosis, staging, and follow-up by international societies. It also describes radiologic utility in assessing recurrence and postoperative mimics. The objective is to provide radiologists and clinicians with imaging guidance useful at various stages of STS management.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Hussein M, Gupta H, Ahuja A, et al. Imaging recommendations for soft-tissue sarcomas: model guidelines from diagnosis to post-treatment follow-up. Clin Radiol. 2024. PMID: 39289073. doi:10.1016/j.crad.2024.08.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。